semaglutide slidel Pharmacological Profile Of Synthesis PPT Summary ACP PPT Slide Semaglutide

8,9 The prevalence of overweight and obesity is a public health issue that has severe cost implications to healthcare systems

Semaglutide should be discontinues and not restarted if this complication should arise

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist

This suggests that TSH changes observed during semaglutide treatment are likely a physiological response to weight loss rather than a direct drug effect (Reinehr, 2010, Thyroid )

Pharmaceuticals (Basel) 2023

Starting Dose The recommended starting dosage of Semaglutide or Compounded Semaglutide is 0.25 mg weekly for the first month (5 units on the syringe). This amount is just meant to introduce the medication into your system so it can begin acclimation